Eric R Olson
Officer at Syros Pharmaceuticals, Inc. (SYRS)
Eric R Olson has filed 10 insider reports with the SEC since February 2021, as officer at Syros Pharmaceuticals, Inc. (SYRS). Eric R Olson made no open-market purchases or sales in the last 12 months. In the latest filing, on July 19, 2023, Eric R Olson sold 689 shares of Syros Pharmaceuticals, Inc. (SYRS) for $2,412 at an average of $3.50.
- Filings
- 10
- Companies
- 1
- Bought on market
- None
- Sold on market
- $50.9K
Companies where Eric R Olson is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | 6,661 | $50.9K | Jul 19, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 17, 2023-$2,412SYRSSEC Form 4 filed by Olson Eric RForm 4Open-market sale10b5-1 plan
- Apr 3, 2023SYRSSEC Form 4 filed by Olson Eric RForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 16, 2023SYRSSEC Form 4 filed by Olson Eric RForm 4Grant or award
- Oct 6, 2022SYRSSEC Form 4 filed by Olson Eric RForm 4Grant or award
- Apr 1, 2022SYRSSEC Form 4: Olson Eric R covered exercise/tax liability with 27,266 shares, decreasing direct ownership by 31% to 59,734 units (for tax liability)Form 4Shares withheld for taxes or exercise price
- Feb 15, 2022SYRSSEC Form 4 filed by Olson Eric RForm 4Grant or award
- Jan 5, 2022-$7,655SYRSSEC Form 4: Olson Eric R sold $7,655 worth of shares (2,208 units at $3.47) as part of a pre-agreed trading plan, closing all direct ownership in the companyForm 4Open-market sale10b5-1 plan
- Jul 1, 2021-$6,460SYRSSEC Form 4: Olson Eric R sold $6,460 worth of Common Stock (1,164 units at $5.55), closing all direct ownership in the companyForm 4Open-market sale10b5-1 plan
- Mar 15, 2021-$34.4KSYRSSEC Form 4: R Eric Olson exercised 3,628 units of Common Stock at a strike of $1.01 and sold $34,372 worth of Common Stock (3,628 units at $9.47)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 17, 2021SYRSSEC Form 4 filed by R Eric OlsonForm 4Grant or award
Compare Eric R Olson with
- Eric R Olson vs Marsha Fanucci1 shared
- Eric R Olson vs Peter Wirth1 shared
- Eric R Olson vs Srinivas Akkaraju1 shared
- Eric R Olson vs Richard A Young1 shared
- Eric R Olson vs Nancy A Simonian1 shared
- Eric R Olson vs Kristin Stephens1 shared
Other insiders at the same companies
- Marsha FanucciSYRS
- Peter WirthSYRS
- Srinivas AkkarajuSYRS
- Flagship Ventures Fund IV, LPSYRS
- Richard A YoungSYRS
- Nancy A SimonianSYRS
- Gerald E QuirkSYRS
- Kristin StephensSYRS
- David RothSYRS
- Conley CheeSYRS
- Jason HaasSYRS
Questions about Eric R Olson
- What is Eric R Olson's role at Syros Pharmaceuticals, Inc.?
- Eric R Olson reports to the SEC as officer at Syros Pharmaceuticals, Inc. (SYRS), according to the latest filing on July 19, 2023.
- How many shares does Eric R Olson own?
- After the latest filing that states it, Eric R Olson directly owned 6,661 shares of Syros Pharmaceuticals, Inc. (SYRS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eric R Olson bought or sold stock recently?
- The most recent open-market sale was on July 17, 2023: sold 689 shares of Syros Pharmaceuticals, Inc. (SYRS) for $2,412 at an average of $3.50.
- How do I get alerts when Eric R Olson files?
- Follow Eric R Olson on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Eric R Olson (SEC CIK 0001678149). Totals count each trade once, skipping amendments whose original is on file, from Feb 19, 2021 on. View on SEC EDGAR · Get this as JSON